NEW YORK (TheStreet) -- In late March, I introduced the BITES portfolio, which was comprised of five names trading at seemingly cheap valuations. The idea was to develop a concentrated tracking portfolio of small technology companies that might appear enticing even to deep value investors. While technology is an area that I have generally avoided, over the past several years a few of my deep value screens have been chock full of smaller technology companies trading at seemingly compelling valuations. Some of these names have been depressed for so long, trading very close to their net current asset values that I began to wonder whether this was simply the new normal for these companies. Each of the BITES names met the following criteria:
- Minimum market cap of $250 million
- Trading for less than 2 times net current asset value
- Profitable during trailing 12 months
- Forward price-to-earnings ratio is less than current P/E
- Long-term debt to equity is less than 30%
- All are technology related names
Despite the 10% run-up since March, the BITES portfolio still appears to be very cheap. Weighting all five of the names equally, the portfolio trades at just 1.56 times net current asset value (NCAV), 1.09 times book value, 0.49 times price to sales, and a forward price earnings ratio just under 12. The average market cap is about $1.65 billion. The companies also remain cash rich, with each having at least 12% of their current market cap in cash, with an average of $335 million in cash per company.